Related Experiment Video
Updated: Aug 13, 2025
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
SMARCA4 vulnerability in H3K27M midline glioma: A silver bullet for a lethal disease
Carol C L Chen1, Augusto Faria Andrade1, Nada Jabado2
1Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.
Abstract:
To investigate epigenetic dependencies and identify therapeutic vulnerabilities, Mo et al.1 and Panditharatna et al.2 performed CRISPR screens and show that deadly H3K27M gliomas are dependent on mammalian BAF (SWI/SNF) chromatin remodeling complex.
Insights
Deadly H3K27M gliomas rely on the mammalian BAF (SWI/SNF) chromatin remodeling complex. This finding reveals potential therapeutic vulnerabilities for treating these aggressive brain tumors.
Area of Science:
- Oncology
- Epigenetics
- Genomics
Background:
- H3K27M gliomas are aggressive brain tumors with limited treatment options.
- Epigenetic alterations play a crucial role in glioma development and progression.
Purpose of the Study:
- To identify epigenetic dependencies in H3K27M gliomas.
- To uncover potential therapeutic vulnerabilities for H3K27M glioma treatment.
Main Methods:
- CRISPR screens were employed to systematically assess gene function.
- Functional genomic screening was used to identify essential genes and pathways.
Main Results:
- H3K27M gliomas exhibit a dependency on the mammalian BAF (SWI/SNF) chromatin remodeling complex.
- The study highlights the critical role of the BAF complex in maintaining the oncogenic state of these gliomas.
Conclusions:
- Targeting the BAF complex represents a promising therapeutic strategy for H3K27M gliomas.
- Understanding epigenetic dependencies can guide the development of novel cancer therapies.
More Related Videos
09:26Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020